Wealth Enhancement Advisory Services
GOSS icon

Wealth Enhancement Advisory Services’s Gossamer Bio GOSS Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-1,924
Closed -$22K – 4315
2026
Q2 		$22K Buy
1,924
+631
+49% +$14.1K ﹤0.01% 4025
2026
Q1 		$29.1K Buy
1,293
+993
+331% +$125K ﹤0.01% 3476
2025
Q4 		$59.3K Buy
300
+60
+25% +$13.7K ﹤0.01% 3522
2025
Q3 		$48K Buy
+240
New +$42.3K ﹤0.01% 3436

Other funds holding GOSS

Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
Planning Strategies
Planning Strategies Lancaster, Pennsylvania $169M AUM
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Wealth Enhancement Advisory Services's GOSS Position: Q3 2026 in Review

Wealth Enhancement Advisory Services sold out of Gossamer Bio (GOSS) in Q3 2026, closing a stake of 1,924 shares — an estimated $22K sold.

Wealth Enhancement Advisory Services first reported a position in GOSS in Q3 2025 and held it in 4 quarters. The position peaked at $59.3K in Q4 2025. 9 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

  • Wealth Enhancement Advisory Services reported no remaining Gossamer Bio position as of Q3 2026 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 1,924 Gossamer Bio shares in Q3 2026, an estimated $22K.
  • Wealth Enhancement Advisory Services first reported a position in Gossamer Bio in Q3 2025 and held it in 4 quarters.
  • Wealth Enhancement Advisory Services's Gossamer Bio position peaked at $59.3K in Q4 2025.
  • 9 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.